MedPath

Tecartus

Trade Name: Tecartus

Generic Name: Brexucabtagene autoleucel

Valid
Registration Number

1505257389

Registration Year

2025

Drug Type

Biological

Legal Status

Prescription

Detailed Information

Comprehensive information about this SFDA approval including dosage forms, packaging, and storage conditions.

Dosage and Strength Information

Cell suspension for infusion

Not specified

Intravenous use

Bag

Storage and Shelf Life

Stored frozen at ≤ −150 °C in vapor phase of liquid nitrogen

12 Months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.